Page 145 of 295« First...102030...143144145146147...150160170...Last »

With cutting-edge antibody technology.

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. With cutting-edge antibody technology, Genmab’s created first class discovery, development and extensive pipeline of developed an extensive pipeline of for potential treatment of of a variety of diseases, including cancer and autoimmune diseases. Genmab advances towards a commercial future, we remain committed to. Our primary goal of improving the lives of patients who are in urgent new treatment options For more information on Genmab ‘s products and technology, visit.

It should also be a focus on engaging the public about how they take action and others, their own health to ensure that we maximize the benefits of the NHS resources We want to engage with the government, and others, about the many areas that have been marked, and we look forward to productive discussions. Continue reading

Abortion rights opponents consistently argue thatquestions about abortion do not affect the law.

The article quotes the Governor role in the appointment of board members govern physicians and the public health department in enforcing the reporting requirements. Sebelius has appointed the current attorney general and will will select four out of the seven state Supreme Court justices. Abortion – rights opponents ‘consistently argue that’questions about abortion do not affect the law, but they are enforced so that their significant influence, the AP / Daily News reports.

In the past, Daily News examined Kan. Governor Sebelius ‘ role in state abortion debates, disputesThe AP / Hays Daily News on Saturday examined Kansas Gov. Kathleen Sebelius ‘ role abortion issues in the state. AP AP / Daily News, Sebelius, who supports abortion rights , is a key figure in all debates. Continue reading

Another study bewertungen.html.

Another study, similar canagliflozin reduced A1C levels and body weight significantly more than Sanofi diabetes pill Amaryl. J & J applied for U bewertungen.html .S. Approval of its drug on 29 That’s because the global obesity epidemic has caused a similar explosion of diabetes cases -. About 95 % have type 2 diabetes, usually with obesity and lack of physical activity together. Once known as adult-onset diabetes, is now diagnosed in adolescents, as insulin-dependent type 1 diabetes, which are used as juvenile diabetes.

A secondary analysis of the results revealed a statistically significant slowing of cognitive decline in patients with mild Alzheimer’s disease, but not in patients with moderate Alzheimer’s, the company said on Friday. Continue reading

August 2012 / PRNewswire / Pharma Manufacturing and Quality[ China 2012.

Manufacture of sterile Manufacturing & Quality Management China 2012 is UpcomingAbout 5000 Chinese pharmaceutical companies are facing challenges related to hardware and software updates as follows:SHANGHAI, August 2012 / PRNewswire / Pharma Manufacturing and Quality[ China 2012, organized by CPhI conferences, on 6 be held – 7 November in Suzhou,China’s new GMP regulation in force on 1 March 2011 in force. There are only 154 of 5,000 pharmaceutical companies in China, which GMP inspection GMP inspection by the end of 2011.

GE Cancer Mapping TechnologyGE scientists have developed new molecular pathology technology that can create a visual map of more than 25 proteins in a single tissue sample at the sub – cellular level and apply sophisticated imaging analysis tools to collect and interpreting the data developed. With the ability to study multiple proteins in a sample, could GE technology more insight than ever before into the signaling networks and cell activity, may provide different types of cancer various types of cancer.. Continue reading

NIMH and NIDA are part of the National Institutes of Health.

NIMH and NIDA are part of the National Institutes of Health , the Federal Government. Primary agency for biomedical and behavioral research NIH is a component of the U.S. Department of Health and Human Services.

‘Most of the patients in this study had large tumors, high grade prostate cancer and were at high risk for cancer spread We are very encouraged by the results and have started another phase II study. Another novel androgen signaling inhibitor MDV3100 in the neoadjuvant setting for high-risk prostate cancer. We are also developing a clinical program studied the addition of the investigational ARN509 to abiraterone to prove is the overall benefit of intensive androgen deprivation therapy in combination with prostatectomy a large randomized clinical study needs to be done. Continue reading

Page 145 of 295« First...102030...143144145146147...150160170...Last »